Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic

View ORCID ProfileH Bonilla, TC Quach, A Tiwari, AE Bonilla, View ORCID ProfileM Miglis, P Yang, View ORCID ProfileL Eggert, View ORCID ProfileH Sharifi, View ORCID ProfileA Horomanski, A Subramanian, L Smirnoff, N Simpson, H Halawi, O Sum-Ping, A Kalinowski, Z Patel, R Shafer, L. Geng
doi: https://doi.org/10.1101/2022.08.03.22278363
H Bonilla
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H Bonilla
  • For correspondence: hbonilla{at}stanford.edu
TC Quach
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Tiwari
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AE Bonilla
2University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Miglis
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M Miglis
P Yang
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Eggert
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L Eggert
H Sharifi
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H Sharifi
A Horomanski
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Horomanski
A Subramanian
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Smirnoff
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Simpson
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Halawi
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O Sum-Ping
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Kalinowski
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z Patel
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Shafer
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Geng
1Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Background The global prevalence of PASC is estimated to be present in 0·43 and based on the WHO estimation of 470 million worldwide COVID-19 infections, corresponds to around 200 million people experiencing long COVID symptoms. Despite this, its clinical features are not well defined.

Methods We collected retrospective data from 140 patients with PASC in a post-COVID-19 clinic on demographics, risk factors, illness severity (graded as one-mild to five-severe), functional status, and 29 symptoms and principal component symptoms cluster analysis. The Institute of Medicine (IOM) 2015 criteria were used to determine the ME/CFS phenotype.

Findings The median age was 47 years, 59·0% were female; 49·3% White, 17·2% Hispanic, 14·9% Asian, and 6·7% Black. Only 12·7% required hospitalization. Seventy-two (53·5%) patients had no known comorbid conditions. Forty-five (33·9%) were significantly debilitated. The median duration of symptoms was 285·5 days, and the number of symptoms was 12. The most common symptoms were fatigue (86·5%), post-exertional malaise (82·8%), brain fog (81·2%), unrefreshing sleep (76·7%), and lethargy (74·6%). Forty-three percent fit the criteria for ME/CFS.

Interpretations Most PASC patients evaluated at our clinic had no comorbid condition and were not hospitalized for acute COVID-19. One-third of patients experienced a severe decline in their functional status. About 43% had the ME/CFS subtype.

Funding The study did not received funding.

  • PASC
  • ME/CFS
  • Symptoms

Competing Interest Statement

Hector Bonilla, MD. Consultant for United Health. Tom C Quach, BS. No conflicts. Anushri Tiwari, BS. No conflicts. Andres Bonilla, BS. No conflicts. Mitchel Miglis, MD. Dysautonomia International Embr, Inc; Elsevier Royalties; 2nd MD, Infinite MD, Guidepoint LLC ; Med-IQ ; Van Cott and Talamante, LLC; Phillip Yang, MD. No conflicts. Lauren Eggert, MD. No conflicts. Husham Sharifi, MD. No conflicts. Audra Horomanski, MD. No conflicts. Aruna Subramanian, MD. No conflicts. Liza Smirnoff, MD. No conflicts. Norah Simpson, PhD. No conflicts. Houssam Halawi, MD. No conflicts. Oliver Sum-Ping, MD. No conflicts. Agnieszka Kalinowski, MD, PhD. Consultant for Pasethia. Zara M. Patel, MD. Elsevier, Springer, Wolters Kluwer, Medtronic, InfiniteMD, Regeneron/Sanofi, Johnson & Johnson, Scientific Advisory Board for Optinose and Dianosic, Patent filed on my behalf by Stanford OTL: S15-465 63/076,656 (S31-06935.PRO) Equity in Olfera Therapeutics, Robert Shafer, MD. Gilead Sciences GlaxoSmithKline, Linda Geng, MD PhD. Consultant for United Health Care

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Stanford University Institutional Review Board

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 04, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic
H Bonilla, TC Quach, A Tiwari, AE Bonilla, M Miglis, P Yang, L Eggert, H Sharifi, A Horomanski, A Subramanian, L Smirnoff, N Simpson, H Halawi, O Sum-Ping, A Kalinowski, Z Patel, R Shafer, L. Geng
medRxiv 2022.08.03.22278363; doi: https://doi.org/10.1101/2022.08.03.22278363
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic
H Bonilla, TC Quach, A Tiwari, AE Bonilla, M Miglis, P Yang, L Eggert, H Sharifi, A Horomanski, A Subramanian, L Smirnoff, N Simpson, H Halawi, O Sum-Ping, A Kalinowski, Z Patel, R Shafer, L. Geng
medRxiv 2022.08.03.22278363; doi: https://doi.org/10.1101/2022.08.03.22278363

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13402)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5181)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4224)
  • Public and Global Health (7526)
  • Radiology and Imaging (1716)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)